Dr. Gregory A. Liguori is the Director of the Anesthesiology Department and Anesthesiologist-in-Chief at Hospital for Special Surgery.
Dr. Liguori is an accomplished clinical anesthesiologist, specializing in regional anesthesia and acute pain medicine in orthopaedics. He also has a number of research interests and has published dozens of articles and book chapters on a variety of topics related to his clinical interests. Dr. Liguori directs one of the largest training programs in the world for the advanced study of regional anesthesiology and acute pain medicine.
He chairs and contributes to numerous department, hospital, and national committees and editorial boards, and has lectured on a variety of topics at local, national, and international venues.
Anesthesiologist-in-Chief, Hospital for Special Surgery
Associate Attending Anesthesiologist, Hospital for Special Surgery
Clinical Associate Professor of Anesthesiology, Weill Cornell Medical College
Regional Anesthesia for Ambulatory Surgery
Hemodynamic Complications of Regional Anesthesia
American Society of Regional Anesthesia
American Society of Anesthesiologists
International Anesthesia Research Society
Society for Education in Anesthesia
New York State Society of Anesthesiologists
Brigham and Women's Hospital
Harvard Medical School
Diplomate, American Board of Anesthesiology - 1994
National Board of Medical Examiners - 1990
For more publications, please see the PubMed listing.
Dr. Gregory Liguori's research efforts are focused on two primary areas. The first is hemodynamic effects of regional anesthetics. Peripheral nerve blockade and neuraxial anesthetics can have significant hemodynamic effects on both healthy and cardio-vascularly compromised patients. Prevention of these events and treatment when necessary are essential to the conduct of safe and efficient anesthetics.
The second area of interest is on spinal anesthesia for ambulatory surgery. The local anesthetic mepivacaine is a novel alternative to other more common local anesthetics for ambulatory spinal anesthesia. We are investigating the efficacy of mepivacaine as a routine alternative in this setting.